Procainamide Antibody (706): sc-57986

Procainamide Antibody (706) is a mouse monoclonal IgG2a antibody that detects Procainamide in non-species reactive samples by enzyme-linked immunosorbent assay (ELISA). Procainamide is a class Ia antiarrhythmic drug that plays a crucial role in managing cardiac arrhythmias by inhibiting sodium channels, which prolongs cardiac action potential and slows conduction velocity. This mechanism helps stabilize heart rhythm, particularly in cases of supraventricular and ventricular arrhythmias, reducing the risk of life-threatening complications. Anti-Procainamide antibody (706) allows precise quantification and monitoring of drug levels in clinical settings, essential for optimizing therapeutic efficacy and minimizing adverse effects. Notably, Procainamide is metabolized into N-acetyl procainamide, an active metabolite excreted through the renal system, highlighting the importance of renal function in drug pharmacokinetics. Procainamide (706) monoclonal antibody serves as an invaluable tool for researchers and clinicians, facilitating a deeper understanding of drug pharmacological profile and impact on cardiac health.